Patent ID: 8106097

Claim:
A method of treatment of pathologies related to deregulations of lipid and/or glucose metabolism comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising one or more pharmaceutically acceptable excipients or vehicles and at least one substituted 1,3-diphenylprop-2-en-1-one derivative represented by formula (I) below: wherein: X1 represents a halogen or a —R1 group or a group corresponding to the following formula: -G1-R1, X2 represents a hydroxy or an unsubstituted alkyloxy group having from one to seven carbon atoms, X3 represents a —R3 group, X4 represents a group corresponding to the following formula: -G4-R4, X5 represents a —R5 group, X6 is an oxygen atom, R1, R3, R5, which are the same or different, represent a hydrogen group or an unsubstituted alkyl group having from one to seven carbon atoms, G1, G4, which are the same or different, represent an oxygen or sulfur atom, R4 represents an alkyl group having from one to seven carbon atoms containing one substituent having the formula —COOR6, with R6 representing a hydrogen atom or an alkyl group having from one to seven carbon atoms, and the optical and geometrical isomers, racemates, tautomers, salts and mixtures thereof; said pathologies being selected from the group consisting of diabetes, atherosclerosis and obesity.